Helicobacter pylori is not a risk factor for hepatic encephalopathy

被引:19
作者
Calvet, X
Nogueras, C
Roqué, M
Sanfeliu, I
机构
[1] Corp Sanitaria Parc Tauli, Med Serv, Barcelona 08208, Spain
[2] Corp Sanitaria Parc Tauli, Epidemiol Serv, Barcelona 08208, Spain
[3] Corp Sanitaria Parc Tauli, Microbiol Lab, Barcelona 08208, Spain
来源
DIGESTIVE AND LIVER DISEASE | 2001年 / 33卷 / 05期
关键词
encephalopathy; Helicobacter pylori; liver cirrhosis;
D O I
10.1016/S1590-8658(01)80013-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Helicobacter pylori infection has been described as a risk factor for hepatic encephalopathy in patients with chronic liver disease although the topic remains controversial. Aims. To determine whether Helicobacter pylori infection is an independent predictive factor for encephalopathy in patients with liver cirrhosis. Methods. Clinical, epidemiological, analytical and nutritional parameters of 205 patients were collected. Helicobacter pylori infection was determined by serology. Encephalopathy (grade II or higher] was clinically assessed during follow-up. The relationship between each parameter and encephalopathy was analysed by Kapfan-Meier curves and the Log rank test. The most significant parameters underwent multivariate analysis by Cox regression. Results. Twenty-five variables were related to encephalopathy in the bivariate analysis. Multivariate analysis selected five independent factors: previous bouts of encephalopathy (Odds ratio 3.79, 95% confidence interval 1.94-7.38), albumin (Odds ratio 0.86; 95% confidence interval 0.80-0.92), tricipital skin fold (Odds ratio 0.79; 95% confidence interval 0.66-0.95] chronic pulmonary disease [Odds ratio 2.78, 95% confidence interval; 1.31-5.92), and on-going alcoholism [Odds ratio 2.62; 95% confidence interval 1.16-5.88). Conclusions. Helicobacter pylori is not an independent risk factor for hepatic encephalopathy.
引用
收藏
页码:414 / 419
页数:6
相关论文
共 31 条
[1]   GASTROINTESTINAL UREASE IN MAN .I. ACTIVITY OF MUCOSAL UREASE [J].
AOYAGI, T ;
ENGSTROM, GW ;
EVANS, WB ;
SUMMERSKILL, WH .
GUT, 1966, 7 (06) :631-+
[2]   Seroprevalence and epidemiology of Helicobacter pylori infection in patients with cirrhosis [J].
Calvet, X ;
Navarro, M ;
Gil, M ;
Mas, P ;
Rivero, E ;
Sanfeliu, I ;
Brullet, E ;
Campo, R ;
Dalmau, B ;
Lafont, A .
JOURNAL OF HEPATOLOGY, 1997, 26 (06) :1249-1254
[3]  
Calvet X, 1998, AM J GASTROENTEROL, V93, P2501, DOI 10.1111/j.1572-0241.1998.00711.x
[4]   ACCURACY OF INVASIVE AND NONINVASIVE TESTS TO DIAGNOSE HELICOBACTER-PYLORI INFECTION [J].
CUTLER, AF ;
HAVSTAD, S ;
MA, CK ;
BLASER, MJ ;
PEREZPEREZ, GI ;
SCHUBERT, TT .
GASTROENTEROLOGY, 1995, 109 (01) :136-141
[5]  
Dasani BM, 1998, AM J GASTROENTEROL, V93, P726, DOI 10.1111/j.1572-0241.1998.214_a.x
[6]  
GIL M, 1996, GASTROENTEROL HEP S1, V19, pA51
[7]  
GUBBINS GP, 1993, AM J GASTROENTEROL, V88, P1906
[8]   Hepatic encephalopathy in chronic liver disease:: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? [J].
Häussinger, D ;
Kircheis, G ;
Fischer, R ;
Schliess, F ;
vom Dahl, S .
JOURNAL OF HEPATOLOGY, 2000, 32 (06) :1035-1038
[9]  
IMOTO I, 1989, J GASTROEN HEPATOL, V4, P75
[10]   HYPERAMMONEMIA AND HELICOBACTER-PYLORI [J].
ITO, S ;
MIYAJI, H ;
AZUMA, T ;
LI, YM ;
ITO, Y ;
KATO, T ;
KOHLI, Y ;
KURIYAMA, M .
LANCET, 1995, 346 (8967) :124-125